These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 18687081)

  • 21. Predictors of a negative response to topiramate therapy in patients with chronic migraine.
    Rothrock JF; Parada VA; Drinkard R; Zweifler RM; Key KF
    Headache; 2005; 45(7):932-5. PubMed ID: 15985112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study.
    Shaygannejad V; Janghorbani M; Ghorbani A; Ashtary F; Zakizade N; Nasr V
    Headache; 2006 Apr; 46(4):642-8. PubMed ID: 16643559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety.
    Winner P; Gendolla A; Stayer C; Wang S; Yuen E; Battisti WP; Nye JS
    Headache; 2006; 46(10):1503-10. PubMed ID: 17115983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topiramate in Migraine Prevention: A 2016 Perspective.
    Silberstein SD
    Headache; 2017 Jan; 57(1):165-178. PubMed ID: 27902848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topiramate in migraine prevention.
    Silberstein SD
    Headache; 2005 Apr; 45 Suppl 1():S57-65. PubMed ID: 15833091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing clinically meaningful treatment effects in controlled trials: chronic migraine as an example.
    Dodick DW; Turkel CC; DeGryse RE; Diener HC; Lipton RB; Aurora SK; Nolan ME; Silberstein SD
    J Pain; 2015 Feb; 16(2):164-75. PubMed ID: 25464159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topiramate for migraine prevention.
    Wenzel RG; Schwarz K; Padiyara RS
    Pharmacotherapy; 2006 Mar; 26(3):375-87. PubMed ID: 16503717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topiramate improves health-related quality of life when used to prevent migraine.
    Diamond M; Dahlöf C; Papadopoulos G; Neto W; Wu SC
    Headache; 2005 Sep; 45(8):1023-30. PubMed ID: 16109116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topiramate in migraine prophylaxis: data from a pooled analysis and open-label extension study.
    Bussone G; Usai S; D'Amico D
    Neurol Sci; 2006 May; 27 Suppl 2():S159-63. PubMed ID: 16688622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topiramate in migraine progression.
    Ruiz L; Ferrandi D
    J Headache Pain; 2009 Dec; 10(6):419-22. PubMed ID: 19838625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topiramate (topamax) for prevention of migraine.
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1136-7. PubMed ID: 15863557
    [No Abstract]   [Full Text] [Related]  

  • 33. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
    Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
    Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topiramate in the treatment of chronic migraine.
    Silvestrini M; Bartolini M; Coccia M; Baruffaldi R; Taffi R; Provinciali L
    Cephalalgia; 2003 Oct; 23(8):820-4. PubMed ID: 14510929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacology of topiramate in migraine prevention.
    Ferrari A; Tiraferri I; Neri L; Sternieri E
    Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1169-81. PubMed ID: 21756204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2002 Sep; 42(8):796-803. PubMed ID: 12390644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of pregabalin versus topiramate in the prophylaxis of chronic daily headache with analgesic overuse: an open-label prospective study.
    Rizzato B; Leone G; Misaggi G; Zivi I; Diomedi M
    Clin Neuropharmacol; 2011; 34(2):74-8. PubMed ID: 21412201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New therapeutic developments in chronic migraine.
    Lovell BV; Marmura MJ
    Curr Opin Neurol; 2010 Jun; 23(3):254-8. PubMed ID: 20442572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial.
    Mohammadianinejad SE; Abbasi V; Sajedi SA; Majdinasab N; Abdollahi F; Hajmanouchehri R; Faraji A
    Clin Neuropharmacol; 2011; 34(4):174-7. PubMed ID: 21738025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.